FXYD5 and colorectal carcinoma: As CRC cells progressed, as indicated by KRAS expression, the expression of tumor acidosis markers (LAMP2, GLUT1, and LDHA), as well as dysadherin, also increased (Fig. 1b, Supplementary Fig. 1c).